Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Middleton

Showing results (411-420 of 522) with videos related to

Pageof 53
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 15, 2018
Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF melanoma (PACMEL): a multicentre, open-label, randomised, controlled phase II trialV Urbonas, D Schadendorf, L Zimmer, et al.
Science Immunology|October 1, 2021
Immune checkpoint blockade sensitivity and progression-free survival associates with baseline CD8<sup>+</sup> T cell clone size and cytotoxicityRobert A Watson, Orion Tong, Rosalin Cooper, et al.
Cellular Oncology (Dordrecht, Netherlands)|December 20, 2022
WNT5A-ROR2 axis mediates VEGF dependence of BRAF mutant melanomaNicholas Coupe, Lina Guo, Esther Bridges, et al.
British Journal of Cancer|April 16, 2009
A phase I study of extended dosing with lomeguatrib with temozolomide in patients with advanced melanomaR F Kefford, N P B Thomas, P G Corrie, et al.
BMJ Open|April 24, 2024
The Birth and Beyond (BABY) study: protocol for a birth cohort study investigating the social and environmental determinants of pregnancy-related outcomes in Black American familiesBetty Lin, Rachel R Middleton, Bethlehem Terefe, et al.
Cancer|July 25, 2003
Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinomaSarah Danson, Mark R Middleton, Kenneth J O'Byrne, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|December 12, 2012
Processing LHC data in the UKD Colling, D Britton, J Gordon, et al.
Elife|December 10, 2024
Tissue-resident natural killer cells support survival in pancreatic cancer through promotion of cDC1-CD8 T activitySimei Go, Constantinos Demetriou, Giampiero Valenzano, et al.
Journal of Dairy Science|May 22, 2017
Prevalence of non-aureus staphylococci species causing intramammary infections in Canadian dairy herdsLarissa A Z Condas, Jeroen De Buck, Diego B Nobrega, et al.
Journal of Medicinal Chemistry|December 19, 1998
Inactivation of O6-alkylguanine-DNA alkyltransferase. 1. Novel O6-(hetarylmethyl)guanines having basic rings in the side chainR S McElhinney, D J Donnelly, J E McCormick, et al.
Pageof 53

Showing results (411-420 of 522) with videos related to

Sort By:
Pageof 53
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 15, 2018
Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF melanoma (PACMEL): a multicentre, open-label, randomised, controlled phase II trialV Urbonas, D Schadendorf, L Zimmer, et al.
Science Immunology|October 1, 2021
Immune checkpoint blockade sensitivity and progression-free survival associates with baseline CD8<sup>+</sup> T cell clone size and cytotoxicityRobert A Watson, Orion Tong, Rosalin Cooper, et al.
Cellular Oncology (Dordrecht, Netherlands)|December 20, 2022
WNT5A-ROR2 axis mediates VEGF dependence of BRAF mutant melanomaNicholas Coupe, Lina Guo, Esther Bridges, et al.
British Journal of Cancer|April 16, 2009
A phase I study of extended dosing with lomeguatrib with temozolomide in patients with advanced melanomaR F Kefford, N P B Thomas, P G Corrie, et al.
BMJ Open|April 24, 2024
The Birth and Beyond (BABY) study: protocol for a birth cohort study investigating the social and environmental determinants of pregnancy-related outcomes in Black American familiesBetty Lin, Rachel R Middleton, Bethlehem Terefe, et al.
Cancer|July 25, 2003
Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinomaSarah Danson, Mark R Middleton, Kenneth J O'Byrne, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|December 12, 2012
Processing LHC data in the UKD Colling, D Britton, J Gordon, et al.
Elife|December 10, 2024
Tissue-resident natural killer cells support survival in pancreatic cancer through promotion of cDC1-CD8 T activitySimei Go, Constantinos Demetriou, Giampiero Valenzano, et al.
Journal of Dairy Science|May 22, 2017
Prevalence of non-aureus staphylococci species causing intramammary infections in Canadian dairy herdsLarissa A Z Condas, Jeroen De Buck, Diego B Nobrega, et al.
Journal of Medicinal Chemistry|December 19, 1998
Inactivation of O6-alkylguanine-DNA alkyltransferase. 1. Novel O6-(hetarylmethyl)guanines having basic rings in the side chainR S McElhinney, D J Donnelly, J E McCormick, et al.
Pageof 53